Evidence map›Paper›PMID 41749922›Full record

ArticleCancers2026

Investigating CAR-T Treatment Access for Multiple Myeloma Patients Using Real-World Evidence.

Jaysón Davidson, Anupama Kumar, Ayan Patel, Irene Y Chen, Atul J Butte, Travis Zack

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jaysón DavidsonBakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0001-9066-9872
Anupama KumarDepartment of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143, USA.
Ayan PatelCenter for Data-Driven Insights and Innovation, University of California Health, Oakland, CA 94607, USA.
Irene Y ChenComputational Precision Health, University of California San Francisco, San Francisco, CA 94158, USA.
Atul J ButteBakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-7433-2740
Travis ZackBakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA 94158, USA.

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer InequitiesU54CA280811 · NCI · STANFORD UNIVERSITY · PI MELISSA L. BONDY, Luis Guillermo Carvajal Carmona · 2023 to 2026
$10.8M
FDA HHS U01 FD005978NCATS NIH HHS UL1 TR001872NCI NIH HHS U54 CA280811
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CAR-T eligibilityCAR-T therapyhealthcare disparitiesmultiple myeloma

Identifiers

PMID41749922
PMCPMC12938920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.